Detalhe da pesquisa
1.
Impact of a Formal Advance Care Planning Program on End-of-Life Care for Patients With Heart Failure: Results From a Randomized Controlled Trial.
J Card Fail
; 26(7): 594-598, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31991216
2.
Instability in End-of-Life Care Preference Among Heart Failure Patients: Secondary Analysis of a Randomized Controlled Trial in Singapore.
J Gen Intern Med
; 35(7): 2010-2016, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32103441
3.
Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore.
Expert Rev Pharmacoecon Outcomes Res
; 24(5): 631-641, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38776431